{"id":"W2262803926","doi":"10.3111/13696998.2016.1141780","title":"Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada); Pfizer (Canada)","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Apixaban; Venous thromboembolism; Intensive care medicine; Internal medicine; Warfarin; Atrial fibrillation; Rivaroxaban; Thrombosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005931453,0.0001223698,0.0009203509,0.00006327592,0.0000206251,0.000004580135,0.0000813521,0.00006294875,0.00003517187],"category_scores_gemma":[0.00004164861,0.00005898662,0.0001061243,0.00001589853,0.000140151,0.00004651133,0.00002050589,0.00005951101,1.447199e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004735065,"about_ca_system_score_gemma":0.001388515,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02346768,"about_ca_topic_score_gemma":0.2789576,"domain_scores_codex":[0.9987147,0.00003474349,0.0008524227,0.0001463979,0.000109595,0.0001421439],"domain_scores_gemma":[0.9986386,0.0004635105,0.0005327008,0.0001438288,0.00003770433,0.000183597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0005742957,0.001201888,0.02324362,0.00005931984,0.0008676196,0.000006838858,0.000247732,0.00004740537,0.000003779297,0.001221579,0.0001647397,0.9723612],"study_design_scores_gemma":[0.02795544,0.03206834,0.9203218,0.001635399,0.001630975,0.0001966686,0.0009398981,0.0008515541,0.0004955395,0.001104533,0.01258507,0.0002147763],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924411,0.002427763,0.00005088,0.00427244,0.0002761816,0.0004780784,0.00002495399,9.499896e-7,0.00002771635],"genre_scores_gemma":[0.9131542,0.08632721,0.0002413473,0.00007250827,0.0001656013,0.00001632079,0.000001188905,0.00001044244,0.00001121857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9721464,"threshold_uncertainty_score":0.9830351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03019685173148177,"score_gpt":0.305182404215438,"score_spread":0.2749855524839562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}